Briefing
Briefings report OHE research and, on occasion, that of other experts.
Incentives to follow Best Practice in Health Care
1 February 2015
There has been long-standing interest in the use of incentives to encourage delivery of high-quality health care services at the lowest feasible cost. There has been…
What is the Role of HTA for Biosimilars?
1 April 2014
This Briefing summarises the results of a roundtable convened by OHE to discuss using HTA to assess biosimilars – including which methods are most appropriate in…
Causes of Death: A Study of a Century of Change in England and Wales
1 October 2012
This Briefing extends to 2007 Thomas McKeown’s well-known analysis of changes in life expectancy in England during 1901-1971. It finds that mortality continued to decline after 1971,…
Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries
1 November 2009
This study compares pricing and reimbursement (P&R) policy for 43 orphan medicinal products (OMPs) across seven EU Member States: France, Germany, Italy, The Netherlands, Spain, Sweden…
Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?
1 October 2009
In this Briefing, five leading European experts in health economics provide a comprehensive international review of changes in health economic evaluation and the reasons for them. …
How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to NHS Patients in England
1 September 2009
Written while Labour Government policies still were in force, this Briefing clearly and thoroughly examines non-discretionary cost differences between public and independent providers that may have…
Deliberative Processes in Decisions about Health Care Technologies
1 June 2009
In the UK and elsewhere, choices about how to allocate health care resources are guided not only by economic calculations, but also by social value judgments…
American Exceptionalism and American Health Care: Implications for the US Debate on Cost-Effectiveness Analysis
1 March 2009
Coined by the French historian Alexis de Tocqueville in the early nineteenth century, the term ’American exceptionalism’ refers to the idea that the US is different…
The Impact of Health Technology Assessment on Drug Development
3 January 2009
Health technology assessment (HTA) has become a critical basis for pricing and reimbursement decision-making worldwide. In some countries, extensive requirements for data are set out in…